Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Categoría del artículo: Research Article

Publicado en línea: 21 feb 2018

Páginas: 281 - 288

Recibido: 22 nov 2017

Aceptado: 30 nov 2017

DOI: https://doi.org/10.2478/raon-2018-0009

Palabras clave

locally advanced NSCLC, survival, immunotherapy, PD-L1 expression, chemoradiotherapy

© 2018 Martina Vrankar, Karmen Stanic, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.